Mechanical stimulation reduces sclerostin expression in rodents. However, few data are available about the effect of physical stimuli in human systems. Recently we observed that the demethylating agent AzadC induces SOST expression in bone cells. This allowed us in this study to explore the effect of mechanical loading on SOST expression by subjecting AzadC-treated human bone cells to pulsating fluid flow (PFF). PFF significantly decreased the AzadC-induced expression of SOST. This effect persisted for at least 24 h, and in fact SOST expression was lower at 24 h after PFF treatment than at 1 h after PFF treatment (PFF/static ratio 0.47 ± 0.04 vs. 0.63 ± 0.03 respectively, p = 0.03). The PFF-induced decrease in SOST expression was not due to...
Bone unloading results in osteocyte apoptosis, which attracts osteoclasts leading to bone loss. Load...
Intermittent parathyroid hormone (PTH) application is an established pharmacological principle to st...
Nitric oxide (NO) can reduce bone loss in chronic bone diseases. NO inhibits or kills osteoclasts, b...
Mechanical stimulation reduces sclerostin expression in rodents. However, few data are available abo...
Both mechanical loading and nitric oxide (NO) have positive influences on bone mass. NO production i...
Strain-derived flow of interstitial fluid activates signal transduction pathways in osteocytes that ...
Strain-derived flow of interstitial fluid activates signal transduction pathways in osteocytes that ...
Exercise promotes positive bone remodeling through controlling cellular processes in bone. Nitric ox...
We have previously shown that prostaglandins (PG) and nitric oxide (NO) are required in the inductio...
Bone has the capacity to alter its mass and structure to its mechanical environment. Osteocytes are ...
Sclerostin (Sost) is a negative regulator of bone formation that acts upon the Wnt signaling pathway...
Contains fulltext : 69701.pdf (publisher's version ) (Closed access)Bone unloading...
Endothelial nitric oxide synthase (eNOS) has long been held responsible for NO production by mechani...
Multiple factors contribute to bone loss in inflammatory diseases such as rheumatoid arthritis (RA),...
AbstractWe have developed an experimental model whereby bone is exposed to a brief episode of mechan...
Bone unloading results in osteocyte apoptosis, which attracts osteoclasts leading to bone loss. Load...
Intermittent parathyroid hormone (PTH) application is an established pharmacological principle to st...
Nitric oxide (NO) can reduce bone loss in chronic bone diseases. NO inhibits or kills osteoclasts, b...
Mechanical stimulation reduces sclerostin expression in rodents. However, few data are available abo...
Both mechanical loading and nitric oxide (NO) have positive influences on bone mass. NO production i...
Strain-derived flow of interstitial fluid activates signal transduction pathways in osteocytes that ...
Strain-derived flow of interstitial fluid activates signal transduction pathways in osteocytes that ...
Exercise promotes positive bone remodeling through controlling cellular processes in bone. Nitric ox...
We have previously shown that prostaglandins (PG) and nitric oxide (NO) are required in the inductio...
Bone has the capacity to alter its mass and structure to its mechanical environment. Osteocytes are ...
Sclerostin (Sost) is a negative regulator of bone formation that acts upon the Wnt signaling pathway...
Contains fulltext : 69701.pdf (publisher's version ) (Closed access)Bone unloading...
Endothelial nitric oxide synthase (eNOS) has long been held responsible for NO production by mechani...
Multiple factors contribute to bone loss in inflammatory diseases such as rheumatoid arthritis (RA),...
AbstractWe have developed an experimental model whereby bone is exposed to a brief episode of mechan...
Bone unloading results in osteocyte apoptosis, which attracts osteoclasts leading to bone loss. Load...
Intermittent parathyroid hormone (PTH) application is an established pharmacological principle to st...
Nitric oxide (NO) can reduce bone loss in chronic bone diseases. NO inhibits or kills osteoclasts, b...